Advancements in therapeutically targeting orphan GPCRs

Por Stockert, Jennifer A., Devi, Lakshmi A.
Publicado no Front Pharmacol (2015)

Predictive value of pseudouridine in prostate cancer

Por Stockert, Jennifer A, Gupta, Akriti, Herzog, Bryan, Yadav, Shalini S, Tewari, Ashutosh K, Yadav, Kamlesh K
Publicado no Am J Clin Exp Urol (2019)

Induction of Neuroendocrine Differentiation in Prostate Cancer Cells by Dovitinib (TKI-258) and its Therapeutic Implications

Por Yadav, Shalini S., Li, Jinyi, Stockert, Jennifer A., Herzog, Bryan, O'Connor, James, Garzon-Manco, Luis, Parsons, Ramon, Tewari, Ashutosh K., Yadav, Kamlesh K
Publicado no Transl Oncol (2017)

Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer

Por Yadav, Shalini Singh, Li, Jinyi, Stockert, Jennifer A., O'Connor, James, Herzog, Bryan, Elaiho, Cordelia, Galsky, Matthew D., Tewari, Ashutosh Kumar, Yadav, Kamlesh Kumar
Publicado no Oncotarget (2016)

Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake

Por Wardman, Jonathan H., Gomes, Ivone, Bobeck, Erin N., Stockert, Jennifer A., Kapoor, Abhijeet, Bisignano, Paola, Gupta, Achla, Mezei, Mihaly, Kumar, Sanjai, Filizola, Marta, Devi, Lakshmi A.
Publicado no Sci Signal (2016)